Study to Evaluate Efficacy of Micardis® (Telmisartan) and Valsartan in Patients With Mild-to-moderate Hypertension After Missing One Dose Using Ambulatory Blood Pressure Monitoring

NCT02242318 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

440

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: Telmisartan
DRUG: Valsartan
DRUG: Placebo

Sponsor

Boehringer Ingelheim